Enhanced Imaging Technique May Help Identify Clinical Trial Participants

Just because a photoreceptor has stopped working due to the effects of a retinal degenerative disease doesn’t mean it’s forever lost. In fact, as the Foundation reported previously, José Sahel, M.D., a researcher at the Institut de la Vision in Paris, is developing a treatment to reactivate cones which have lost their light-sensing, antenna-like projections known as outer segments, but still retain their cell bodies, or inner segments.

Louisiana Family Helps Lead to Discovery of New RP Gene

A new gene linked to autosomal dominant retinitis pigmentosa (adRP) has been identified, thanks to a Foundation Fighting Blindness-funded genetic study that began with an Acadian family from Louisiana whose vision loss can be traced back to the early 1800s. Led by Stephen Daiger, Ph.D., at the University of Texas Health Science Center in Houston, an international research collaborative found that mutations in the gene HK1 cause

Stem-Cell-Derived Treatment for Retinal Diseases Safe Thus Far in Human Study

Widely reported research published last week in the medical journal The Lancet spells good news for the Massachusetts-based Advanced Cell Technology (ACT) and its emerging retinal-disease treatment. Results from two early clinical trials indicate there were no serious adverse events associated with its stem-cell-derived therapy. Also, it appeared to improve vision in some patients with two kinds of macular

Annual Report

Driving Research - Saving Sight — read about the research and fundraising efforts helping to end blindness in the Foundation Fighting Blindness’ 2017 Annual Report.